University of California, Davis: Carcinoma, Non-Small-Cell Lung trials

The registry lists 14 Carcinoma, Non-Small-Cell Lung studies with University of California, Davis as lead sponsor. 4 are open to participants now and 4 have results posted.

Early Phase 1 4Phase 1 7Phase 2 5No phase 1(a study in two phases counts in both)

Studies

Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• Risk-adapted, Proteomic-guided Systemic Therapy for Previously Untreated Advanced Non-small Cell Lung CancerRecruitingNCT07250477Phase 2
• Molecularly Targeted Radionuclide Therapy Via the Integrin Alphavbeta6RecruitingNCT06228482Phase 1
• LOcally ABLatIve ThErapy for OligopRogressive Lung And Thoracic MalignanciEs (OBLITERATE)RecruitingNCT06103682Not applicable
• Fluorine-18-AlphaVBeta6-Binding Peptide Positron Emission Tomography in Metastatic Non-Small Cell Lung CancerRecruitingNCT05452005Phase 1
• [18F]F-AraG/Total Body PET Imaging and Healthy Subjects and Lung Cancer PatientsCompletedNCT04678440Early Phase 1Results posted
• Study of Dovitinib and Biomarkers in Advanced Non-Small Cell Lung Cancer or Advanced Colorectal CancerCompletedNCT01676714Phase 2Results posted
• Erlotinib and Cetuximab in Treating Patients With Advanced Solid Tumors With Emphasis on Non-Small Cell Lung CancerCompletedNCT00408499Phase 1/2Results posted
• Bortezomib and Pemetrexed Disodium in Treating Patients With Advanced Non-Small Cell Lung Cancer or Other Solid TumorsCompletedNCT00389805Phase 1/2Results posted
• [18F]-AraG for the Detection of T-Cell Activation in Advanced Non-small Cell Lung Cancer Patients Undergoing PD-1/PD-L1-Directed TherapyWithdrawnNCT04186988Early Phase 1
• UCDCC#269: A Pilot Study of Interlesional IL-2 and RT in Patients With NSCLC.CompletedNCT03224871Early Phase 1
• INC280 and Erlotinib Hydrochloride in Treating Patients With Non-small Cell Lung CancerCompletedNCT01911507Phase 1
• Study of Cisplatin and Pemetrexed in Combination With Panobinostat in Solid TumorsCompletedNCT01336842Phase 1
• Clinical Study of Microdosing Carboplatin in Lung or Bladder CancerTerminatedNCT01261299Early Phase 1
• Pemetrexed Disodium and Erlotinib in Treating Patients With Advanced Non-Small Cell Lung Cancer or Other Solid TumorsCompletedNCT00387322Phase 1/2